Keisha Masters, MS’ Post

𝗘𝗺𝗯𝗿𝗮𝗰𝗶𝗻𝗴 𝗶𝗻𝘀𝘁𝗲𝗿𝘀𝗲𝗰𝘁𝗶𝗼𝗻𝗮𝗹𝗶𝘁𝘆 𝗶𝗻 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 : 𝗔𝗹𝗶𝗰𝗲 𝗔𝘂𝗴𝘂𝘀𝘁𝗮 𝗕𝗮𝗹𝗹'𝘀 𝗿𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗮𝗿𝘆 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗳𝗼𝗿 𝗛𝗮𝗻𝘀𝗲𝗻'𝘀 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 (𝗹𝗲𝗽𝗿𝗼𝘀𝘆). 【Ｃｈａｐｔｅｒ　６】 Despite her significant contributions to medicine, Ball's work went largely unrecognized during her lifetime and for decades afterward; however, recent efforts have begun to restore her legacy and honor her achievements. Living at the intersection of multiple marginalized identities - being both African American and a woman in the early 20th century - Ball faced numerous obstacles. However, it was perhaps these very challenges that fostered her unique perspective and approach to scientific problems. https://lnkd.in/eWQZq_Xf #sustainability #science #womeninscience #corporatesocialresponsibility ----------------------------------------------- 𝚃𝚛𝚒𝚊𝚗𝚘𝚗 𝚂𝚌𝚒 𝙲𝚘𝚖𝚖 𝚒𝚜 𝚊 𝚖𝚊𝚗𝚊𝚐𝚎𝚖𝚎𝚗𝚝 𝚌𝚘𝚗𝚜𝚞𝚕𝚝𝚒𝚗𝚐 𝚏𝚒𝚛𝚖 𝚜𝚙𝚎𝚊𝚌𝚒𝚊𝚕𝚒𝚜𝚎𝚍 𝚒𝚗 𝙲𝚂𝚁 𝚊𝚗𝚍 𝚜𝚞𝚜𝚝𝚊𝚒𝚗𝚊𝚋𝚒𝚕𝚒𝚝𝚢 𝚜𝚝𝚛𝚊𝚝𝚎𝚐𝚢. 𝚆𝚎 𝚑𝚎𝚕𝚙 𝚋𝚞𝚜𝚒𝚗𝚎𝚜𝚜 𝚖𝚊𝚔𝚎 𝚜𝚞𝚜𝚝𝚊𝚒𝚗𝚊𝚋𝚒𝚕𝚒𝚝𝚢 𝚙𝚛𝚘𝚏𝚒𝚝𝚊𝚋𝚕𝚎, 𝚋𝚢 𝚌𝚘𝚗𝚗𝚎𝚌𝚝𝚒𝚗𝚐 𝚎𝚗𝚟𝚒𝚛𝚘𝚗𝚖𝚎𝚗𝚝𝚊𝚕, 𝚜𝚘𝚌𝚒𝚊𝚕 𝚊𝚗𝚍 𝚎𝚌𝚘𝚗𝚘𝚖𝚒𝚌 𝚜𝚞𝚜𝚝𝚊𝚒𝚗𝚊𝚋𝚒𝚕𝚒𝚝𝚢.

"Changing the world starts with one person at a time." Ever wonder we opt for pricey, temporary fixes for our sight when a more efficient, effective solution exists? 🤔 Check out our #TBT to #TedxOmaha and Dr. Kugler's eye-opening exploration of the global myopia epidemic and the life-changing functional, safety, and financial impact of modern vision correction. 🔍👁️ #Myopiaawarenessweek #VisionCorrection #ClearSightClearMind #LASIKOmaha #SEEOmaha https://bit.ly/44II7fc

🎙️ Tune in to EP4 of #InTheLeadwithUCEA, Diversity and Equity. Uncover the transformative power of profound learning experiences in fostering healing. #LeadershipMatters #UCEAWallace 🎧 https://ow.ly/pcZ850Q6LIz

🎙️ Tune in to EP4 of #InTheLeadwithUCEA, Diversity and Equity. Uncover the transformative power of profound learning experiences in fostering healing. #LeadershipMatters #UCEAWallace 🎧 https://ow.ly/pcZ850Q6LIz

I'm so thankful to RARE Revolution Magazine and Kielo Research for allowing me to steal some pages from the Autumn issue to talk about something I'm really passionate about, Patient Preferences in Rare Diseases. 🎙 Nicola Miller interviewed me about two months ago, and we discussed what patient preferences mean in the concept of drug development and regulatory submissions. We talked about challenges faced when conducting these types of studies in rare diseases and some of the strategies currently in practice to try to overcome them, but most importantly we talked about the value these studies could offer to any stakeholder working in drug development for rare diseases, and I highlighted how is a field in which patient advocacy groups can be (and have been) the initiators of the project (go to page 52 to know more). #patientpreferences #raredisorders #RD 💚 Besides all that, I could not asked for a better disease spotlight to share this issue with, Mitochondrial Disease 💚 - the one disease group (together with DM1) with which I conducted my first-ever patient preferences study. So, please take a look at the whole issue, there you will see inspirational stories like: 🕯 MitoHOPE - a consortium led by Monash University in Australia to support safe and efficient mitochondrial donation (interview with Professor David Thorburn) 3️⃣ The three pillars of advocacy by The Lily Foundation 🌎 Jo de Bry from MitoAction talks about international efforts to integrate knowledge and data in mitochondrial disorders and support the progress of new therapies 🎨 A presentation of how art and science DO collide by researcher Gavin McStay and artist Charlotte Morrison 💌 And stories like the one of little 3-year-old Alex Hewitt-Camacho and his family, whose lives have been put upside down and then up again with a diagnosis that can be shortly read (TK2d) but is far from that to be understood. And how support from communities such as the United Mitochondrial Disease Foundation can make a difference when feeling hopeless on that rollercoaster that, no matter how much I try, I would never be able to really understand. 🍀 I also saw familiar names listed on it (e.g., the amazing Professor Robert MacFarland and Philip Yeske) and made me smile And I could keep going on and on - but better you guys take a look! You can access the full Autumn using this link:  https://lnkd.in/epAKYnvQ

Discover the latest insights on #dystoniaresearch in our upcoming March webinar. It will be followed by a support meeting. Dystonia and Quality of Life – Recent Research and Implications 🗓️ March 16, 2024 ⏱️ 11 am MT/1 PM ET - Please Check your Corresponding Time Zone Register Today. https://ow.ly/x07h50Qtzw2 #dystoniatreatment #dystoniaawareness

When we believe in science and American ingenuity.

The newest edition of Clinical Insights features an article by Tracee S. Dahm, MS, RDH, about Eruption cysts and what to look for. Click here to learn more and subscribe to Clinical Insights now: https://bit.ly/4cvVBOT

PulseSelect PFA long term durability study! Proven safety and proven durabilty.

Be part of the our mission to save sight, change lives! In 2024 - 2029 we aim to continue funding a thriving pipeline of vision research and our brand new research strategy explains just how you can get involved. Head to https://lnkd.in/eiPy798x Video text: Introducing our new research strategy. We exist to save sight, change lives. Which is why we fund research that aims to understand, treat, prevent, and diagnose eye conditions and diseases. A video in the background shows someone using a microscope.